Difficulty: Medium
Average Score: 79%
Practice
Addition of pyrazinamide and ethambutol for the first two months to the isoniazid + rifampin therapy of tuberculosis serves the following purpose(s)
Correct answer
D
Rationale
In the treatment of tuberculosis, the addition of pyrazinamide and ethambutol alongside isoniazid and rifampin for the first two months serves multiple purposes. The correct answer, option D, is the most appropriate because it combines the benefits of reducing the total duration of therapy to 6 months and producing more rapid sputum conversion.
Pyrazinamide and ethambutol are added in the initial phase to quickly reduce the bacterial load, leading to faster sputum conversion and symptom resolution. This combination is potent against mycobacteria and helps prevent the development of drug resistance.
Option A, reducing the total duration of therapy to 6 months, is correct because the intensive phase with these four drugs for the initial two months is crucial for achieving successful treatment outcomes, making it possible to shorten the overall treatment duration.
Option B is incorrect because the primary purpose of adding pyrazinamide and ethambutol is not to permit the reduction of rifampin dose but to enhance the effectiveness of the treatment regimen.
Option C is incorrect because the addition of pyrazinamide and ethambutol does not permit a reduction in the rifampin dose; rather, it complements the action of rifampin in combating tuberculosis bacteria effectively.
Educationally, understanding the rationale behind combining specific drugs in tuberculosis treatment is essential for healthcare providers to ensure optimal patient care. Knowing the synergistic effects of different drugs and their roles in treatment regimens helps in achieving successful treatment outcomes and preventing drug resistance.
Pyrazinamide and ethambutol are added in the initial phase to quickly reduce the bacterial load, leading to faster sputum conversion and symptom resolution. This combination is potent against mycobacteria and helps prevent the development of drug resistance.
Option A, reducing the total duration of therapy to 6 months, is correct because the intensive phase with these four drugs for the initial two months is crucial for achieving successful treatment outcomes, making it possible to shorten the overall treatment duration.
Option B is incorrect because the primary purpose of adding pyrazinamide and ethambutol is not to permit the reduction of rifampin dose but to enhance the effectiveness of the treatment regimen.
Option C is incorrect because the addition of pyrazinamide and ethambutol does not permit a reduction in the rifampin dose; rather, it complements the action of rifampin in combating tuberculosis bacteria effectively.
Educationally, understanding the rationale behind combining specific drugs in tuberculosis treatment is essential for healthcare providers to ensure optimal patient care. Knowing the synergistic effects of different drugs and their roles in treatment regimens helps in achieving successful treatment outcomes and preventing drug resistance.